Point72 Hong Kong LTD Cara Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$11.99 - $18.14 $43,547 - $65,884	-3,632 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.55 - $16.06 $41,949 - $58,329	3,632 New	3,632 $56,000
Q1 2021 May 17, 2021	SELL	$15.07 - $21.71 $21,625 - $31,153	-1,435 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$12.72 - $16.16 $1,488 - $1,890	-117 Reduced 7.54%	1,435 $22,000
Q3 2020 Nov 16, 2020	BUY	$12.34 - $17.92 $19,151 - $27,811	1,552 New	1,552 $20,000
Q1 2020 May 15, 2020	SELL	$9.12 - $17.78 $20,592 - $40,147	-2,258 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.11 - $25.98 $34,137 - $55,051	2,119 Added 1524.46%	2,258 $36,000
Q3 2019 Nov 14, 2019	BUY	$18.28 - $26.91 $2,540 - $3,740	139 New	139 $3,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.